Key facts
- Notable investors include Enterprise Ireland, Aleap, Norwegian University of Science and Technology, St. Olavs Hospital HF.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Keimon Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Keimon Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Keimon Medical
Provider of outpatient device-based treatments intended for pain relief purposes. The company's platform offers a minimally invasive, repeatable, and office-based approach characterized by high throughput and a favorable safety profile, enabling the medical market to access cost-effective, long-term processes for a range of pain conditions with improved efficacy and reduced adverse events.
- Sector
- Healthcare
- HQ
- Trondheim, Norway
- Founded
- 2022
- Website
- keimonmedical.com/
- Ownership
- Privately Held (backing)
Keimon Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Keimon Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Keimon Medical in its N-PORT filings yet. We sweep new filings monthly.